Page 2 - Stefano Colloca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Bill and Melinda Gates Foundation has awarded a grant of $1.4 million to Italian biotech firm ReiThera for the development of covid-19 and HIV vaccines.

/PRNewswire/ -- ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and...

Program funded by the Bill & Melinda Gates Foundation will use ReiThera's GRAd platform technology to develop next generation vaccines against SARS-CoV-2 emerging variants and HIV ROME

Reuters Reuters 21 July, 2021, 2:10 pm Vials labelled "Moderna, Johnson & Johnson, Pfizer-BioNTech coronavirus disease (COVID-19) vaccine" are seen in this illustration picture taken May 2, 2021. REUTERS/Dado Ruvic CHICAGO, July 20 (Reuters) – Scientists are working on a benchmark for COVID-19 vaccine efficacy that would allow drugmakers to conduct smaller, speedier human trials to get them to market and address a huge global vaccine shortage. Researchers are trying to determine just what level of COVID-19 antibodies a vaccine must produce to provide protection against the illness. Regulato...

Jul 21, 2021 CHICAGO – Scientists are working on a benchmark for COVID-19 vaccine efficacy that would allow drugmakers to conduct smaller, speedier human trials to get them to market and address a huge global vaccine shortage. Researchers are trying to determine just what level of COVID-19 antibodies a vaccine must produce to provide protection against the illness. Regulators already use such benchmarks — known as correlates of protection — to evaluate flu vaccines without requiring large, lengthy clinical trials. “You could use it to predict efficacy from a vaccine, which wi...